U.S. market Closed. Opens in 1 day 6 hours 34 minutes

VIRI | Virios Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/A
Operating Expenses5.45M12.32M15.64M10.01M2.18M
Selling, General & Admin3.72M4.25M4.85M9.81M1.34M
Research & Development1.73M8.07M10.80M194.01K836.17K
Other Operating ExpensesN/A67.47K-319.33K-341.00KN/A
Operating Income-5.45M-12.32M-15.64M-10.01M-2.18M
Other Expenses / Income150.90K67.47K-319.33K-341.00K-295.13K
Before Tax Income-5.30M-12.25M-15.96M-10.35M-2.47M
Income Tax Expenses-5.45K-67.47K-15.64K-10.01K295.13K
Net Income-5.30M-12.18M-15.96M-10.35M-2.77M
Interest ExpensesN/AN/A5.67K384.22K295.13K
Basic Shares Outstanding18.78M11.07M8.33M8.31M8.28M
Diluted Shares Outstanding18.78M11.07M8.33M8.31M8.28M
EBITDA150.90K-12.32M-15.64M-10.01M-295.13K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-5.30M-12.25M-15.97M-9.97M-2.18M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙